To take a simplistic view I always look at a companies Cash Flow statement at the operational level.
This gives you a basic view of how the company is faring at the hard core base level of running their day-to-day business.
It includes (only) the cash flow from running the business:
Receipts from customers
Payments to suppliers & employees
Financing Costs
Interest received
Interest Paid
+/- income taxes.
At this level the company experienced a cash outflow of $7.5mio.
Now obviously, if a company is going to reduce their debt it has to come from the cash flow of their day-to-day business or selling off assets.
CDR's banker's will be looking for a reduction in their exposure, so where is the money for this going to come from?
Cleary CDR are going to either (a) lift income and/or (b) reduce costs - was this issue addressed at the AGM (wasn't there so I don't know)?
In a nutshell, CDR are bleeding cash at operational level and are going to need a massive reversal of fortunes to change this.
As for a rights issue, well it is fair to say that equity is a lot more expensive to service than debt, and is generally only undertaken as a last resort. A rights issue will immediately devalue the current share holding of existing holders.
The fact CDR have had a series of "vultures" going over their books, and they all said "no thank-you" must tell you something?
- Forums
- ASX - By Stock
- CDR
- earnings guidance
CDR
codrus minerals limited
Add to My Watchlist
5.71%
!
3.3¢

earnings guidance, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
3.3¢ |
Change
-0.002(5.71%) |
Mkt cap ! $6.822M |
Open | High | Low | Value | Volume |
3.4¢ | 3.4¢ | 3.3¢ | $7.374K | 217.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 200000 | 3.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.5¢ | 50000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 200000 | 0.030 |
1 | 250000 | 0.029 |
2 | 428240 | 0.027 |
1 | 40000 | 0.025 |
1 | 25000 | 0.021 |
Price($) | Vol. | No. |
---|---|---|
0.035 | 50000 | 1 |
0.039 | 200000 | 1 |
0.040 | 23148 | 1 |
0.041 | 60193 | 1 |
0.042 | 185016 | 2 |
Last trade - 15.07pm 25/06/2025 (20 minute delay) ? |
Featured News
CDR (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
SPONSORED BY The Market Online